Proteases of Malaria Parasites: New Targets for Chemotherapy

The increasing resistance of malaria parasites to antimalarial drugs is a major contributor to the reemergence of the disease as a major public health problem and its spread in new locations and populations. Among potential targets for new modes of chemotherapy are malarial proteases, which appear t...

Full description

Bibliographic Details
Main Author: Philip J. Rosenthal
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 1998-03-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/4/1/98-0107_article
_version_ 1818910918238535680
author Philip J. Rosenthal
author_facet Philip J. Rosenthal
author_sort Philip J. Rosenthal
collection DOAJ
description The increasing resistance of malaria parasites to antimalarial drugs is a major contributor to the reemergence of the disease as a major public health problem and its spread in new locations and populations. Among potential targets for new modes of chemotherapy are malarial proteases, which appear to mediate processes within the erythrocytic malarial life cycle, including the rupture and invasion of infected erythrocytes and the degradation of hemoglobin by trophozoites. Cysteine and aspartic protease inhibitors are now under study as potential antimalarials. Lead compounds have blocked in vitro parasite development at nanomolar concentrations and cured malaria-infected mice. This review discusses available antimalarial agents and summarizes experimental results that support development of protease inhibitors as antimalarial drugs.
first_indexed 2024-12-19T22:50:26Z
format Article
id doaj.art-8a4a69bbd1c945128232a2247fe0b5ce
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-19T22:50:26Z
publishDate 1998-03-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-8a4a69bbd1c945128232a2247fe0b5ce2022-12-21T20:02:50ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60591998-03-0141495710.3201/eid0401.980107Proteases of Malaria Parasites: New Targets for ChemotherapyPhilip J. RosenthalThe increasing resistance of malaria parasites to antimalarial drugs is a major contributor to the reemergence of the disease as a major public health problem and its spread in new locations and populations. Among potential targets for new modes of chemotherapy are malarial proteases, which appear to mediate processes within the erythrocytic malarial life cycle, including the rupture and invasion of infected erythrocytes and the degradation of hemoglobin by trophozoites. Cysteine and aspartic protease inhibitors are now under study as potential antimalarials. Lead compounds have blocked in vitro parasite development at nanomolar concentrations and cured malaria-infected mice. This review discusses available antimalarial agents and summarizes experimental results that support development of protease inhibitors as antimalarial drugs.https://wwwnc.cdc.gov/eid/article/4/1/98-0107_articleUnited States
spellingShingle Philip J. Rosenthal
Proteases of Malaria Parasites: New Targets for Chemotherapy
Emerging Infectious Diseases
United States
title Proteases of Malaria Parasites: New Targets for Chemotherapy
title_full Proteases of Malaria Parasites: New Targets for Chemotherapy
title_fullStr Proteases of Malaria Parasites: New Targets for Chemotherapy
title_full_unstemmed Proteases of Malaria Parasites: New Targets for Chemotherapy
title_short Proteases of Malaria Parasites: New Targets for Chemotherapy
title_sort proteases of malaria parasites new targets for chemotherapy
topic United States
url https://wwwnc.cdc.gov/eid/article/4/1/98-0107_article
work_keys_str_mv AT philipjrosenthal proteasesofmalariaparasitesnewtargetsforchemotherapy